At a glance
- Originator Aventis
- Class Antihyperglycaemics
- Mechanism of Action Enzyme inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetic complications
Most Recent Events
- 09 May 2003 Discontinued for Diabetic complications in Germany (unspecified route)
- 30 Jan 1997 No-Development-Reported for Diabetic complications in Germany (Unknown route)
- 20 Oct 1994 Investigation in Diabetic complications in Germany (Unknown route)